Alcoholic liver disease
Alcoholic liver disease: when to consider liver transplantation?
... undergo liver transplantation for alcoholic liver disease (ALD), alcohol relapse is ...of liver transplantation with ALD as an indication between Janu- ary 1, 1995 and December 31, ...
16
DEP domain-containing mTOR-interacting protein suppresses lipogenesis and ameliorates hepatic steatosis and acute-on-chronic liver injury in alcoholic liver disease
... attenuates alcoholic hepatic steatosis and liver injury mTORC1 has been appreciated to be implicated in NAFLD (7, 25), but whether and how the mTORC1 pathway is activated by alcohol feeding have yet to be ...
31
The purinergic p2x7 receptor-nlrp3 inflammasome pathway: A new target in alcoholic liver disease?
... patterns. Alcoholic liver steatosis is characterized by the accumulation of lipids in and around the ...of liver damage, affecting more than 90% of individuals who consume four to five standard units ...
14
Hepatic regulation of VLDL receptor by PPARβ/δ and FGF21 modulates non-alcoholic fatty liver disease
... in alcoholic liver disease [19], whereas stimulation of activating transcription factor 4 (ATF4) signaling during endoplasmic reticulum (ER) stress induces hepatic steatosis via increase VLDLR by ...
40
Awareness of the severity of liver disease re-examined using software-combined biomarkers of liver fibrosis and necroinflammatory activity
... Liver disease severity has traditionally been assessed by liver ...severe liver disease, 15 and the centralisation of software-combined biomarkers, such as the FibroTest (FT), 5 16 17 ...
12
European ‘NAFLD Preparedness Index’ — Is Europe ready to meet the challenge of fatty liver disease?
... fatty liver disease (NAFLD), which is closely associated with obesity, metabolic syndrome, and diabetes, is a highly prevalent condition that can be optimally managed through a multidisciplinary ...
8
Rôle du régulateur du cycle cellulaire p16INK4a dans le développement du diabète de type 2 et dans les maladies métaboliques du foie gras ou NAFLD (Non-Alcoholic Fatty Liver Disease) : rôle de p16INK4a dans le contrôle de la néoglucogenèse hépatique et dans le développement de la stéatose hépatique non alcoolique.
... 58 Au niveau de la gouttelette lipidique cytosolique, l’ATGL qui hydrolyse les TG en DG, n’est pas associée à la sécrétion des VLDL mais oriente plutôt les AG vers la β-oxydation (165,166). L’expression d’ATGL est ...
117
SERPINA1 Z allele is associated with cystic fibrosis liver disease
... 17. Pan W. Extending the Iterative Convex Minorant Algorithm to the Cox Model for Interval- Censored Data. Journal of Computational & Graphical Statistics. 1999;8:109--120. 18. Torres-Duran M, Lopez-Campos JL, ...
25
Magnetic resonance-based biomarkers in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
... assess disease activity including ballooning and inflammation in ...to disease activity and fibrosis such as magnetization transfer contrast and diffusion-weighted imaging and T1 mapping, where T1 mapping ...
10
Autochthonous liver cystic hydatid: Past or actual French shepherd's disease?
... © 2020 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license ( http://creativecommons.org/licenses/by/4.0/ ). Introduction Echinococcus granulosus is a cestode of the Tæniidæ ...
4
Tight junction proteins in gastrointestinal and liver disease
... expression of tight junction adhesion proteins in cancer pathogenesis. Claudins: multifunctional players in epithelial tight 1142[r] ...
61
Nonalcoholic fatty liver disease and obstructive sleep apnea
... of liver injury to diagnose NAFLD, Türkay et ...in liver enzymes (in particular ALT) suggesting, again using a non-invasive surrogate of NAFLD, that OSA is associated with liver deterioration ...
28
Liver mitochondrial function in ZDF rats during the early stages of diabetes disease
... and with succinate + rotenone), we surprisingly found that H 2 O 2 release by the respiratory chain was lower in ZDF fa/fa 14w rats as compared to ZDF fa/fa 11w and to ZDF lean 11 and 14w (102 vs. 157; 146 and 123 pmol ...
12
Nonalcoholic Fatty Liver Disease: Modulating Gut Microbiota to Improve Severity?
... 2019;9:5688. 89. Anon. Clinical study of probiotics in treatment of non-alcoholic fatty liver disease-- 《Chinese Journal of Gastroenterology and Hepatology》2013年年03期. Available at: ...
38
Matching Graft Quality to Recipient’s Disease Severity Based on the Survival Benefit in Liver Transplantation
... Results Among the 8387 candidates, 5753 had received liver transplants. Candidate, recipient and donor characteristics are shown in Table 1 . The distribution of LT by MELD and DQI categories appears on Fig. 2 . ...
12
Pharmacokinetic and toxicological considerations for the treatment of diabetes in patients with liver disease.
... of liver metabolism clearly differentiates the PK of metformin from that of other biguanides, such as phenformin (withdrawn from the market because of lactic ...contrast, liver impairment stricto sensu ...
43
QIL1 mutation causes MICOS disassembly and early onset fatal mitochondrial encephalopathy with liver disease
... Liver associated with central nervous system dysfunction is often involved in mitochondrial dis- ease especially those involving defects of mitochondrial DNA maintenance caused by nuclear gene mutations i.e. ...
19
Reduced Incidence and Better Liver Disease Outcomes among Chronic HCV Infected Patients Who Consume Cannabis
... having liver cirrhosis, the complications of liver cirrhosis including ascites, variceal bleeding, hepatorenal syndrome, hepatic encephalopathy, portal hypertension, and jaundice, and other noncirrhotic ...
10
Stimulating healthy tissue regeneration by targeting the 5-HT₂B receptor in chronic liver disease.
... is not detected on any other cellular source of αSMA+ cell in diseased rodent liver 13 . PCNA staining of liver sections revealed treatment with C1-3-gliotoxin stimulates hepatocyte proliferation (fig 1c). ...
36
View of Severe acute alcoholic hepatitis
... De sorte que lorsque la comparaison a été faite dans une autre étude rando- misée avec l ’association G-CSF plus transplantation autolo- gue intra-artérielle hépatique de cellules souche[r] ...
12